A--PRECLINICAL MEDICATIONS SCREENING IN DEPENDENCE MODELS OF ALCOHOL USE DISORDER
ID: 75N94024R00003Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NICHDBETHESDA, MD, 20817, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH (AJ11)
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for a contract focused on preclinical medications screening in models of Alcohol Use Disorder (AUD). The objective of this procurement is to conduct blind testing of compounds supplied by developers using mouse models, with the contractor responsible for generating analyses and reports throughout the project. This initiative is crucial for advancing research in alcohol use disorder treatments and ensuring compliance with NIH policies on reproducibility and animal welfare. Proposals are due by September 18, 2024, with the contract period commencing on December 1, 2024, and extending through November 30, 2031. Interested parties can contact Lisa Schaupp at lisa.schaupp@nih.gov or 301-827-8135 for further information.

    Point(s) of Contact
    Files
    Title
    Posted
    Amendment 01 to RFP 75N94024R00003 outlines special contract requirements regarding information and physical security for government-owned/contractor-operated (GOCO) and contractor-owned/contractor-operated (COCO) systems. Key provisions include compliance with federal security regulations, including the HHS Information Security and Privacy Policy and NIST guidelines. Contractors must obtain a valid Authority to Operate (ATO) within three months post-award, and submit a System Security Plan (SSP) and Plan of Action and Milestones (POA&M) detailing security controls and vulnerability management. Furthermore, contractors must ensure continuous monitoring of IT assets, apply secure coding practices, and facilitate government access for security assessments. The document specifies guidelines for end-of-life software, use of secured devices, data rights, and cybersecurity supply chain risk management. Additionally, contractors are mandated to comply with Section 508 of the Rehabilitation Act regarding electronic accessibility of deliverables. The contract concerns a preclinical testing program for drugs aimed at treating Alcohol Use Disorder and is set to begin on December 1, 2024, lasting 12 months with six options for extension. This RFP emphasizes the government's commitment to upholding stringent security and accessibility standards in conjunction with advancing public health research.
    The document is a compilation of attachments and resources related to federal and state/local Request for Proposals (RFPs) for the National Institutes of Health (NIH). It includes various essential components required for proposal submissions, such as guidelines for proposal packaging, intent response sheets, a statement of work for an Indefinite Delivery Indefinite Quantity (IDIQ) contract, and specified reporting requirements and deliverables. Additional key items consist of technical proposal forms, cost summary links, and compliance certifications, along with instructions for invoicing and financial requests. Furthermore, it outlines specific templates for small business subcontracting plans, government property scheduling, and employee suitability investigations. The document emphasizes the necessity of safeguarding non-public information through contractor agreements. Task orders, including statements of work for pre-clinical contract administration and compound testing, are also described. The comprehensive nature of these attachments indicates a structured approach to facilitate proposals, ensuring clarity and adherence to federal guidelines, thereby supporting the government's procurement processes. This intricate framework reinforces the commitment to maintain robustness and transparency in public spending.
    The "HHS Industry User Guide for Subcontracting Plan Reviews" serves as a comprehensive manual for vendors required to submit subcontracting plans to the Department of Health and Human Services (HHS). The document outlines the process for accessing and reviewing subcontracting plans through the SBCX platform, which includes sections for project information, subcontracting goals, documentation, and communication with HHS officials. Vendors are guided to identify the type of subcontracting plan, report eligible subcontracting expenditures, provide necessary goal data, designate a Subcontracting Program Administrator, and detail efforts to include small businesses. They must certify compliance and submit the plan for approval. The evaluation process involves multiple approvers, ensuring thorough oversight. The guide emphasizes the importance of compliance with subcontracting goals within the context of federal and local RFPs, aligning with broader government objectives to engage small businesses in federal contracting opportunities. The document ultimately facilitates a structured approach to subcontracting plan submissions and reviews, ensuring adherence to government standards.
    The document serves as an amendment to solicitation number 75N94024R00003 issued by the National Institute of Child Health (NICHD), detailing modifications to the initial request related to a contract for "Preclinical Medications Screening in Dependence Models of Alcohol Use Disorder." Key updates include the addition of a new section on information security, revisions to Section M.6 for compliance with Section 508 guidelines, and amendments to Attachment 21 to include the necessary Section 508 language. The performance period for the contract is specified from December 1, 2024, to November 30, 2031. In accordance with federal requirements, offers must acknowledge receipt of this amendment to avoid rejection. The document emphasizes adherence to rigorous standards for information security and accessibility, reflecting the government’s commitment to ensuring equitable access to information and services in the procurement process. This amendment is a formal step in the federal contracting process, aligning with guidelines for soliciting offers and modifying existing contracts.
    The document pertains to Amendment 02 of Solicitation No. 75N94024R00003 issued by the National Institute of Child Health (NICHD), part of the National Institutes of Health (NIH). The amendment outlines important procedural guidelines for potential offerors, emphasizing the necessity of acknowledging receipt of the amendment by a specified date to avoid the rejection of offers. The primary focus is on the solicitation titled "Preclinical Medications Screening in Dependence Models of Alcohol Use Disorder," with a performance period set from December 1, 2024, to November 30, 2031. Key changes in this amendment include provisions for submitting written questions to Ms. Sarah Bank by September 4, 2024, and inclusion of a guide for subcontracting plan reviews. It also updates a specific section to incorporate a link for the SBCX Subcontracting Plan Review. The document reinforces the need for compliance with the call for amendments and modifications applicable to governmental contracts, highlighting the importance of clear communication and documentation in federal contract procedures. Overall, it serves as a crucial resource for contractors interested in the mentioned solicitation, facilitating clarity and proper protocol adherence in the submission process.
    The National Institutes of Health (NIH) issued a Request for Proposals (RFP) for a contract related to preclinical medication screening in models of Alcohol Use Disorder (AUD). The project aims to conduct blind testing of compounds supplied by developers in mice, with analyses and reports to be generated. Proposals are due by September 18, 2024, and the contract period spans from December 1, 2024, to November 30, 2031. This contract, accessible to various small businesses, outlines estimated costs, payment terms, and specific performance requirements, including adherence to NIH policies on reproducibility, animal welfare, and financial conflicts of interest. The contractor will provide all necessary personnel and resources, submitting regular progress reports and ensuring compliance with federal procurement regulations. Rigorous standards for monitoring and response to conflicts of interest are established, emphasizing the contractor’s accountability for transparent research practices. The successful offeror will engage in a structured process for task orders, ensuring alignment with NIH directives and the overall mission of advancing alcohol research.
    Similar Opportunities
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for the preparation and distribution of research drug products under a presolicitation notice. The contract will involve acquiring, importing, and exporting drugs and chemical compounds, as well as developing and analyzing various drug dosage forms, including marijuana and nicotine research cigarettes, to support drug abuse and addiction research. This contract is critical for maintaining a reliable supply of authentic controlled and uncontrolled drug compounds for the research community, with an anticipated award of one indefinite delivery, indefinite quantity (IDIQ) contract over a five-year period. Interested parties must possess a current DEA registration and comply with FDA’s current Good Manufacturing Practices, with proposals due approximately 45 days after the release of the RFP, expected on or about September 20, 2024. For further inquiries, contact Scott Duernberger at scott.duernberger@nih.gov or 301-594-0670.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for Chemistry, Manufacturing, and Controls (CMC) services related to the development of drug substances. The primary objective is to ensure the Division of Preclinical Innovation (DPI) receives drug substances of adequate quality and quantity to support preclinical and Investigational New Drug (IND)-enabling studies, adhering to current Good Manufacturing Practice (cGMP) standards. This procurement is crucial for advancing therapeutics from preclinical stages to market readiness, emphasizing a multidisciplinary approach and compliance with regulatory requirements throughout the drug development pipeline. The Request for Proposals (RFP) is expected to be released on or about October 4, 2024, with contract awards anticipated in the second quarter of FY2025. Interested parties may contact Samson Shifaraw at samson.shifaraw@nih.gov for further information.
    Surveys and Cognitive Tasks
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA) and the National Institute of Mental Health (NIMH), is seeking a vendor for a non-competitive contract to provide account management, planning, and maintenance for online crowd-sourced surveys and cognitive tasks related to depression and anxiety. The primary objective is to facilitate participation in these surveys for individuals both with and without mental health conditions, thereby supporting research efforts in this critical area. This procurement falls under NAICS code 541910, with a contract period of one year, and is scheduled for award on or around September 23, 2024. Interested parties must submit their capability statements and proposals by September 23, 2024, at 9:00 a.m. Eastern Standard Time, to Robin Knightly at Robin.Knightly@nih.gov.
    A--BPCA Pediatric Trials Network
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for an Indefinite Quantity Contract to establish and manage the Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network. This initiative aims to create a robust infrastructure for conducting pediatric clinical trials, emphasizing compliance with federal regulations and ethical standards in research practices. The contract, which has a performance period from May 19, 2025, to May 18, 2033, offers a minimum compensation of $2,500 and a maximum potential value of $149 million, contingent on successful performance. Proposals are due by November 4, 2024, and interested parties can contact Elizabeth J. Osinski at eo43m@nih.gov or 240-550-5028 for further information.
    A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) seek proposals from small businesses for innovative research projects under the Small Business Innovation Research (SBIR) program. The upcoming solicitation, PHS-2025-1, will open on August 2, 2024, with a closing date of October 18, 2024, and aims to foster healthcare technological innovation and commercialization. Research topics span cancer research, aging, and various health concerns. Offerors must demonstrate the technical and commercial viability of their proposals. This solicitation invites applications for Phase I, Fast Track, and Direct to Phase II projects, with evaluations based on scientific merit, commercial potential, and performance quality. Successful small businesses could receive funding for their research initiatives, contributing to NIH and CDC mission objectives.
    Tecniplast Caging Equipment or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified vendors to provide Tecniplast caging equipment or equivalent products for the National Institute of Neurological Disorders and Stroke (NINDS). The procurement aims to replace worn-out caging systems used for housing rodents, which are essential for various research programs, and includes specific requirements for Tecniplast 1145T Blue Line mouse cages, Green Line rat cages, and associated logistics equipment. This contract is set aside for small businesses and will follow simplified acquisition procedures, with a base period of six months and two one-year options, emphasizing firm-fixed pricing. Interested parties must submit their proposals by September 19, 2024, and can contact Frederick Weddington at frederick.weddington@nih.gov or 301-594-6835 for further information.
    Good Manufacturing Practice (GMP)-manufactured Monoclonal Antibody
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to award a sole source contract for the procurement of Good Manufacturing Practice (GMP)-manufactured Monoclonal Antibody UB-421, with a requirement of 100 liters. This procurement is critical for an ongoing clinical trial aimed at treating patients with multidrug-resistant HIV-1 infection, utilizing UB-421, which is exclusively manufactured by United BioPharma, Inc., the sole patent holder and provider of the necessary cell line for production. Interested parties who believe they can meet the specifications must submit a capability statement to the primary contact, Hershea Vance, by 3:00 PM EST on September 20, 2024, as the contract is expected to be awarded within 19 days of this notice, with a performance period from September 23, 2024, to September 24, 2025.
    NIAID Virology Quality Assurance
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is seeking qualified small business sources for the NIAID Virology Quality Assurance (VQA) program. The primary objective is to establish a comprehensive quality assessment program for virologic assays related to HIV and other viral pathogens, ensuring the validity and reliability of laboratory data across approximately 110 laboratories globally. This initiative is crucial for maintaining the scientific integrity of ongoing and future studies concerning HIV diagnosis, treatment, and emerging viral pathogens. Interested parties must submit their capability statements by September 26, 2024, to Shawnice Williams at shawnice.williams@nih.gov, with a focus on demonstrating relevant experience and qualifications.
    Budget Technical and Scientific Resources Staffing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to negotiate a contract for Budget Technical and Scientific Resources Staffing with Remedy Biz, Inc. The objective of this procurement is to secure professional Matter Experts who will provide high-level strategic budget and financial management planning and execution services for the NIH, extending the current contract period from September 23, 2024, to November 30, 2024. This contract is crucial for ensuring effective financial oversight and management within the NIH, which plays a vital role in public health research and funding. Interested small businesses are encouraged to submit their quotes and capabilities to Lisa Ingram at lisa.ingram@nih.gov by September 20, 2024, referencing solicitation number NIH-OLAO-OD5-NOI7077500.
    Automated Liquid Handling Systems– Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of two automated liquid handling systems, either brand name or equal, to support the Vaccine Production Program (VPP) at the National Institute of Allergy and Infectious Diseases (NIAID). These systems are critical for high-throughput, microscale protein purification and product characterization, which are essential for developing vaccines against various pathogens, including HIV and SARS-COV-2. Interested vendors must submit their quotes by 12:00 PM EST on September 23, 2024, to Daveta H. Brown at daveta.brown@nih.gov, ensuring compliance with all specified requirements and regulations outlined in the solicitation documents.